Sarah Gentry1, Jean Craig2, Richard Holland2, Caitlin Notley2. 1. Norwich Medical School, University of East Anglia, Norwich, United Kingdom. Electronic address: sarah.gentry@doctors.org.uk. 2. Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
Abstract
INTRODUCTION: Smoking prevalence among those in substance misuse treatment remains much higher than the general population, despite evidence for effective cessation interventions that do not negatively impact substance misuse outcomes. This systematic review summarises qualitative data on barriers and facilitators to smoking cessation for people in substance misuse treatment, participants' and providers' perceptions about effects of smoking cessation on substance misuse treatment, timing of intervention delivery and aspects of interventions perceived to be effective. METHODS: Systematic review of qualitative studies and thematic synthesis of published qualitative data. RESULTS: 10939 records and 132 full texts were screened. 22 papers reporting on 21 studies were included. Key themes identified were: strong relationships between smoking and other substance misuse; environmental influences; motivation; mental health; aspects of interventions perceived to be effective/ineffective; barriers and facilitators to intervention implementation; smoking bans/restrictions; and relationships with professionals. Many service users were motivated toward smoking cessation but were not offered support. Some felt interventions should be delivered after substance misuse treatment, whilst others felt concurrent/dual interventions would be beneficial, due to strong associations between smoking and other substances. Treatment providers felt they lacked training and resources for supporting smoking cessation, and were concerned about impact on substance misuse outcomes. CONCLUSIONS: Many substance misusers who also smoke are motivated to quit but perceive a lack of support from professionals. Additional training and resources are required to enable professionals to provide the support needed. More research is required to develop enhanced packages of care for this deprived group of smokers.
INTRODUCTION: Smoking prevalence among those in substance misuse treatment remains much higher than the general population, despite evidence for effective cessation interventions that do not negatively impact substance misuse outcomes. This systematic review summarises qualitative data on barriers and facilitators to smoking cessation for people in substance misuse treatment, participants' and providers' perceptions about effects of smoking cessation on substance misuse treatment, timing of intervention delivery and aspects of interventions perceived to be effective. METHODS: Systematic review of qualitative studies and thematic synthesis of published qualitative data. RESULTS: 10939 records and 132 full texts were screened. 22 papers reporting on 21 studies were included. Key themes identified were: strong relationships between smoking and other substance misuse; environmental influences; motivation; mental health; aspects of interventions perceived to be effective/ineffective; barriers and facilitators to intervention implementation; smoking bans/restrictions; and relationships with professionals. Many service users were motivated toward smoking cessation but were not offered support. Some felt interventions should be delivered after substance misuse treatment, whilst others felt concurrent/dual interventions would be beneficial, due to strong associations between smoking and other substances. Treatment providers felt they lacked training and resources for supporting smoking cessation, and were concerned about impact on substance misuse outcomes. CONCLUSIONS: Many substance misusers who also smoke are motivated to quit but perceive a lack of support from professionals. Additional training and resources are required to enable professionals to provide the support needed. More research is required to develop enhanced packages of care for this deprived group of smokers.
Authors: Caitlin Notley; Sarah Gentry; Jonathan Livingstone-Banks; Linda Bauld; Rafael Perera; Jamie Hartmann-Boyce Journal: Cochrane Database Syst Rev Date: 2019-07-17
Authors: Alex S Flitter; Su Fen Lubitz; Douglas Ziedonis; Nathaniel Stevens; Frank T Leone; David Mandell; John Kimberly; Oscar Lopez; Rinad S Beidas; Robert A Schnoll Journal: Nicotine Tob Res Date: 2019-04-17 Impact factor: 4.244
Authors: Melissa A Jackson; Penny Buykx; Amanda L Brown; Amanda L Baker; Adrian J Dunlop; Gillian S Gould Journal: Addict Sci Clin Pract Date: 2022-10-04